1. What is the projected Compound Annual Growth Rate (CAGR) of the Short-Read NGS Data?
The projected CAGR is approximately XX%.
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
Short-Read NGS Data by Type (In-House NGS Data Storage, Outsourced NGS Data Storage), by Application (Data Storage Solutions, Data Analysis Services), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2025-2033
The short-read Next-Generation Sequencing (NGS) data storage market is experiencing robust growth, driven by the increasing adoption of NGS technologies across various applications, including genomics research, precision medicine, and infectious disease surveillance. The market's expansion is fueled by several factors: the decreasing cost of sequencing, the rising volume of genomic data generated, and the growing need for efficient data storage and analysis solutions. The market is segmented into in-house and outsourced data storage solutions, along with data storage and data analysis services. In-house solutions are favored by large research institutions and pharmaceutical companies with significant resources and in-house bioinformatics expertise, whereas outsourced solutions are gaining traction among smaller research groups and diagnostic labs seeking cost-effective and scalable options. The North American region currently holds a significant market share, driven by substantial investments in research and development and a well-established healthcare infrastructure. However, the Asia-Pacific region, particularly China and India, is expected to witness rapid growth in the coming years due to the increasing prevalence of genetic diseases and the expanding genomic research initiatives in these regions. The market faces challenges such as the high cost of data storage and the complexity of data analysis, but advancements in cloud-based storage solutions and the development of advanced bioinformatics tools are mitigating these challenges.
The competitive landscape is characterized by a mix of established players and emerging companies. Major players like Illumina, Roche, and QIAGEN leverage their established presence in the NGS technology market to offer comprehensive data storage and analysis solutions. Specialized companies like DNAnexus and Fabric Genomics focus on providing advanced bioinformatics tools and cloud-based platforms. Future growth will likely be driven by increasing adoption of cloud-based storage and analysis, the development of more sophisticated analytical tools for large datasets, and the increasing integration of NGS data with other omics data for a more holistic understanding of biological systems. The market is projected to exhibit a sustained high growth trajectory, leading to substantial market expansion over the forecast period.
The short-read next-generation sequencing (NGS) data market is experiencing explosive growth, driven by the increasing adoption of NGS technologies across diverse applications in healthcare, agriculture, and environmental science. Over the historical period (2019-2024), the market witnessed a substantial surge, with the volume of data generated exceeding several hundred million gigabases annually. This trend is projected to continue throughout the forecast period (2025-2033), with an estimated market size exceeding several trillion gigabases by 2033. This massive data generation necessitates sophisticated storage and analysis solutions. The estimated year (2025) shows a market value in the tens of billions of dollars, with a Compound Annual Growth Rate (CAGR) significantly above the global average for data storage markets. This growth is fueled by decreasing sequencing costs, improved sequencing accuracy, and the expanding range of applications where NGS is proving invaluable. The market is witnessing a shift towards cloud-based solutions for data storage and analysis, primarily driven by the scalability and cost-effectiveness offered by cloud platforms. This trend is also being influenced by the increasing availability of powerful cloud computing resources that can handle the immense computational demands of NGS data analysis. Simultaneously, the demand for specialized data analysis services is on the rise as researchers require expert support to interpret complex NGS datasets and extract meaningful insights. The interplay of these factors is reshaping the NGS data landscape, creating lucrative opportunities for technology providers, service providers, and data storage companies alike. Furthermore, advancements in artificial intelligence (AI) and machine learning (ML) are revolutionizing data analysis, enabling faster and more accurate interpretation of NGS data, thereby accelerating the pace of research and innovation across multiple fields. The increasing availability of user-friendly analytical tools is further contributing to market expansion by making NGS data analysis more accessible to a broader user base.
Several factors are driving the exponential growth of the short-read NGS data market. The declining cost of sequencing is a major contributor, making NGS technology accessible to a wider range of researchers and clinicians. This affordability, coupled with the increased throughput of modern sequencing platforms, allows for the generation of massive datasets that were previously unattainable. Simultaneously, advancements in sequencing technology have improved accuracy and reduced error rates, leading to more reliable and trustworthy results. The expanding applications of NGS across diverse fields, including precision medicine, infectious disease surveillance, and agricultural genomics, contribute significantly to the increasing demand for short-read sequencing. Precision medicine, in particular, is a major driver, as NGS allows for the personalized treatment of diseases based on an individual's genetic makeup. Additionally, the growing awareness of the importance of genomic data in understanding complex biological systems and diseases further fuels the market's expansion. The increasing adoption of cloud-based solutions for data storage and analysis provides scalability and cost-effectiveness, enabling researchers to efficiently manage and analyze large volumes of NGS data. Finally, the development of sophisticated data analysis tools and algorithms, coupled with the advancements in AI and ML, is enabling faster and more accurate interpretations of NGS data, thus further increasing the appeal of NGS technology.
Despite the remarkable growth, several challenges and restraints hinder the full potential of the short-read NGS data market. The sheer volume of data generated poses significant storage and management challenges, demanding efficient and cost-effective solutions. Data security and privacy are major concerns, requiring robust security measures to protect sensitive genomic information. The complex nature of NGS data analysis requires specialized expertise and sophisticated bioinformatics tools, limiting accessibility for researchers without specialized training. The high cost of data analysis, even with cloud computing solutions, can be a barrier for smaller research groups and institutions. Moreover, the lack of standardized data formats and analysis pipelines can hamper interoperability and data sharing between different research groups and platforms. Integrating NGS data with other types of omics data (e.g., proteomics, metabolomics) poses a significant computational and analytical challenge. Finally, the ethical implications of using genomic data, particularly in clinical applications, necessitate the development of robust ethical guidelines and regulations to ensure responsible use.
The North American and European regions are expected to dominate the short-read NGS data market throughout the forecast period due to the high concentration of research institutions, advanced healthcare infrastructure, and well-established bioinformatics expertise. Within these regions, the United States and Germany are projected to be leading players.
Outsourced NGS Data Storage: This segment is anticipated to experience significant growth, driven by the increasing preference for cloud-based solutions among researchers and healthcare providers. The scalability, cost-effectiveness, and ease of access offered by outsourced storage solutions are key advantages. The shift towards outsourced data storage is facilitated by the rising concerns regarding data security and the need for specialized expertise in data management. Cloud providers are investing heavily in developing specialized solutions for NGS data storage, creating a competitive market with various options for data storage, backup, and disaster recovery. This segment’s growth is also significantly influenced by the ongoing trend of outsourcing bioinformatics analysis, creating a synergy between data storage and analysis services.
Data Analysis Services: This segment shows strong growth, driven by the increasing complexity of NGS data and the need for specialized expertise in data interpretation. Researchers often lack the bioinformatics skills to perform in-depth analysis of large datasets, creating a high demand for outsourced data analysis services. Moreover, the rapid advancements in data analysis techniques, including the integration of AI and ML, are pushing the demand for specialized expertise in managing and interpreting this complex information. This segment is likely to see further diversification as companies offer customized data analysis packages tailored to specific research needs and clinical applications. The integration of data analysis with data storage solutions is likely to form a prominent business model, offering a holistic solution for researchers and clinicians.
The dominance of these segments reflects the growing awareness of the limitations of in-house resources to effectively manage and analyze the ever-increasing volume and complexity of NGS data. The cost and logistical challenges associated with in-house management, in addition to the need for advanced analytical capabilities, make outsourcing a more pragmatic and efficient solution for many organizations.
The continued miniaturization and cost reduction of sequencing technologies, coupled with advancements in bioinformatics and AI-driven data analysis, will act as major growth catalysts. Expanding applications across various sectors, increased public and private funding for genomic research, and the burgeoning field of precision medicine will collectively propel market growth throughout the forecast period. Furthermore, the increasing adoption of cloud computing for data storage and analysis will further contribute to this expansion.
This report offers a comprehensive analysis of the short-read NGS data market, encompassing market size estimations, growth forecasts, segment analysis, key player profiles, and future growth trends. The report provides a detailed examination of the key drivers and restraints shaping the market, and it offers actionable insights for companies operating in or considering entry into this dynamic sector. The report helps to navigate the challenges and exploit the opportunities presented by this rapidly evolving market, providing valuable information for strategic decision-making.
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of XX% from 2019-2033 |
| Segmentation |
|




Note*: In applicable scenarios
Primary Research
Secondary Research

Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately XX%.
Key companies in the market include Agilent Technologies, Inc., BGI Group, DNAnexus, Inc., Fabric Genomics, Inc., Hoffmann-La Roche Ltd. (Roche Molecular Systems, Inc.), Illumina, Inc., PerkinElmer Inc., QIAGEN N.V., Qumulo, Inc., .
The market segments include Type, Application.
The market size is estimated to be USD XXX million as of 2022.
N/A
N/A
N/A
N/A
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
The market size is provided in terms of value, measured in million.
Yes, the market keyword associated with the report is "Short-Read NGS Data," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the Short-Read NGS Data, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.